Posttreatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30)
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Intensified prostate cancer surveillance testing after treatment did not improve overall survival. Higher prostate-specific antigen (PSA) test frequency was linked to more procedures and salvage treatments, not better survival outcomes.
Area Of Science
- Oncology
- Urology
- Health Services Research
Background
- Posttreatment surveillance is crucial for millions of cancer survivors.
- Empirical data guiding clinical practice for prostate cancer surveillance are limited.
- This study investigates the association between surveillance intensity and survival outcomes in localized prostate cancer patients.
Purpose Of The Study
- To assess the association between surveillance testing intensity and overall survival in patients with localized prostate cancer.
- To evaluate the impact of surveillance intensity on recurrence-free survival (RFS).
- To examine the relationship between surveillance intensity and the utilization of diagnostic procedures and salvage treatments.
Main Methods
- A cohort of 10,147 men diagnosed with localized prostate cancer (2005-2010) undergoing radical prostatectomy or radiation therapy was analyzed.
- Surveillance intensity was categorized by the number of prostate-specific antigen (PSA) tests in the first year post-treatment: low (0-1), medium (2), or high (≥3).
- Statistical analysis examined the association between PSA surveillance intensity and overall survival, RFS, and secondary outcomes.
Main Results
- Overall survival did not differ significantly across surveillance intensity groups for either radiation therapy or radical prostatectomy patients.
- Recurrence-free survival (RFS) showed no significant difference for radiation therapy patients but was worse in the high-intensity surveillance group for radical prostatectomy patients (P=.01).
- Higher surveillance intensity correlated with increased use of diagnostic procedures and salvage treatments for both treatment modalities.
Conclusions
- Increased frequency of PSA surveillance testing after radical prostatectomy or radiation therapy for localized prostate cancer is not associated with improved overall survival.
- More intensive surveillance was linked to a higher likelihood of undergoing additional procedures and salvage treatments.
- Current surveillance intensity practices may warrant re-evaluation to optimize patient outcomes and resource utilization.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...